Tocotrienols in Cardiometabolic Medicine: Beyond Classical Vitamin E Activity - Insights from Recent Randomized Controlled Trials and Future Clinical Directions
DOI:
https://doi.org/10.12775/QS.2026.70.74403Keywords
tocotrienols, vitamin E isoforms, cardiometabolic health, metabolic syndrome, NAFLD, type 2 diabetes, oxidative stress, inflammation, microRNAsAbstract
Background: Tocotrienols, lesser-studied members of the vitamin E family, have gained attention because of their pleiotropic biological activities and potential role in cardiometabolic disease. Recent randomized controlled trials (RCTs) indicate benefits beyond α-tocopherol, including antioxidant, anti-inflammatory, and metabolic effects.
Aim: To summarize RCT evidence published between 2020 and 2025 on the effects of tocotrienol supplementation in metabolic syndrome, type 2 diabetes (T2D), non-alcoholic fatty liver disease (NAFLD), and diabetic complications.
Methods: This narrative review included RCTs evaluating tocotrienol supplementation in adults with metabolic disorders. Outcomes included oxidative stress, inflammation, glycaemic control, lipid metabolism, vascular and neural function, and liver injury. Owing to heterogeneity in formulations, doses, and study designs, findings were synthesized narratively.
Results: Tocotrienol supplementation improved biomarkers of oxidative stress, inflammation, and metabolic regulation. In metabolic syndrome, it modulated microRNAs associated with insulin resistance and inflammation. In T2D, δ-tocotrienol reduced HbA1c, fasting glucose, insulin resistance, and malondialdehyde while increasing antioxidant capacity. In NAFLD, δ-tocotrienol reduced inflammatory cytokines and liver injury markers more effectively than α-tocopherol. Tocotrienol-rich vitamin E also improved nerve conduction in diabetic neuropathy and supported renal function in diabetic kidney disease. Supplementation was well tolerated.
Conclusions: Tocotrienols show promising metabolic, anti-inflammatory, and organ-protective effects, particularly in T2D and NAFLD. However, heterogeneity, small sample sizes, and short intervention periods limit definitive conclusions. Larger, standardized, long-term RCTs are needed to confirm their role as adjunctive therapy in cardiometabolic disease.
References
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk | Circulation. (n.d.). Retrieved 4 July 2026, from https://www.ahajournals.org/doi/10.1161/01.cir.0000437740.48606.d1
Aggarwal, B. B., Sundaram, C., Prasad, S., & Kannappan, R. (2010). Tocotrienols, the Vitamin E of the 21st Century: It’s Potential Against Cancer and Other Chronic Diseases. Biochemical Pharmacology, 80(11), 1613–1631. https://doi.org/10.1016/j.bcp.2010.07.043
Al-Baiaty, F. D. R., Ishak, S., Mohd Zaki, F., Masra, F., Abdul Aziz, D. A., Wan Md Zin, W. N., Yee Hing, E., Kuthubul Zaman, A. S., Abdul Wahab, N., Muhammad Nawawi, K. N., Hamid, Z., Raja Ali, R. A., & Mokhtar, N. M. (2024). Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: A single-blind, randomized clinical trial. BMC Pediatrics, 24(1), 529. https://doi.org/10.1186/s12887-024-04993-8
Chuar, P. F., Ng, Y. T., Phang, S. C. W., Koay, Y. Y., Ho, J.-I., Ho, L. S., Botross Henien, N. P., Ahmad, B., & Abdul Kadir, K. (2021). Tocotrienol-Rich Vitamin E (Tocovid) Improved Nerve Conduction Velocity in Type 2 Diabetes Mellitus Patients in a Phase II Double-Blind, Randomized Controlled Clinical Trial. Nutrients, 13(11), 3770. https://doi.org/10.3390/nu13113770
Fatima, S., Khan, D. A., Fatima, F., Aamir, M., Ijaz, A., & Hafeez, A. (2023). Role of δ-tocotrienol and resveratrol supplementation in the regulation of micro RNAs in patients with metabolic syndrome: A randomized controlled trial. Complementary Therapies in Medicine, 74, 102950. https://doi.org/10.1016/j.ctim.2023.102950
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019. (n.d.). https://doi.org/10.1016/j.jacc.2020.11.010
Gozhenko, A., Zukow, W., Gozhenko, O., Pavlega, H., & Popovych, I. (2025). Functional–Metabolic Continuum: A Novel Perspective on the Pathogenesis of Stress-Induced Metabolic Disorders. A problem-oriented review. Pedagogy and Psychology of Sport, 28, 67436. https://doi.org/10.12775/PPS.2025.28.67436
Koay, Y. Y., Tan, G. C. J., Phang, S. C. W., Ho, J.-I., Chuar, P. F., Ho, L. S., Ahmad, B., & Abdul Kadir, K. (2021). A Phase IIb Randomized Controlled Trial Investigating the Effects of Tocotrienol-Rich Vitamin E on Diabetic Kidney Disease. Nutrients, 13(1), 258. https://doi.org/10.3390/nu13010258
Lee, G. Y., & Han, S. N. (2018). The Role of Vitamin E in Immunity. Nutrients, 10(11), 1614. https://doi.org/10.3390/nu10111614
Lopresti, A. L., Smith, S. J., Ding, L., Li, Y., & Zhang, P. (2025). An examination into the effects of tocotrienols (TheraPrimE® rice) on cognitive abilities and sleep in healthy adults: A randomised, double-blind, placebo-controlled trial. Frontiers in Nutrition, 12. https://doi.org/10.3389/fnut.2025.1621516
Mahjabeen, W., Khan, D. A., Mirza, S. A., & Pervez, M. A. (2021). Effects of delta-tocotrienol supplementation on Glycemic Control, oxidative stress, inflammatory biomarkers and miRNA expression in type 2 diabetes mellitus: A randomized control trial. Phytotherapy Research: PTR, 35(7), 3968–3976. https://doi.org/10.1002/ptr.7113
Musa, A. F., Dillon, J., Md Taib, M. E., Yunus, A. M., Sanusi, A. R., Nordin, M. N., & Smith, J. A. (2021). A double-blind randomised controlled trial on the effect of Tocovid, a tocotrienol-rich capsule on postoperative atrial fibrillation at the National Heart Institute, Kuala Lumpur: An interim blinded analysis. Journal of Cardiothoracic Surgery, 16(1), 340. https://doi.org/10.1186/s13019-021-01721-6
Neeland, I. J., Lim, S., Tchernof, A., Gastaldelli, A., Rangaswami, J., Ndumele, C. E., Powell-Wiley, T. M., & Després, J.-P. (2024). Metabolic syndrome. Nature Reviews Disease Primers, 10(1), 77. https://doi.org/10.1038/s41572-024-00563-5
Ng, Y. T., Phang, S. C. W., Tan, G. C. J., Ng, E. Y., Botross Henien, N. P., M Palanisamy, U. D., Ahmad, B., & Abdul Kadir, K. (2020). The Effects of Tocotrienol-Rich Vitamin E (Tocovid) on Diabetic Neuropathy: A Phase II Randomized Controlled Trial. Nutrients, 12(5), 1522. https://doi.org/10.3390/nu12051522
Norazman, C. W., Mohd Sopian, M., & Lee, L. K. (2025). Effects of tocotrienol-enriched oat supplementation on metabolic profile, nutritional status and health-related quality of life among patients with metabolic syndrome. Food & Function, 16(5), 1847–1863. https://doi.org/10.1039/D4FO03307H
Ong, K. L., Stafford, L. K., McLaughlin, S. A., Boyko, E. J., Vollset, S. E., Smith, A. E., Dalton, B. E., Duprey, J., Cruz, J. A., Hagins, H., Lindstedt, P. A., Aali, A., Abate, Y. H., Abate, M. D., Abbasian, M., Abbasi-Kangevari, Z., Abbasi-Kangevari, M., Abd ElHafeez, S., Abd-Rabu, R., … Vos, T. (2023). Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 402(10397), 203–234. https://doi.org/10.1016/S0140-6736(23)01301-6
Pervez, M. A., Khan, D. A., Gilani, S. T. A., Fatima, S., Ijaz, A., & Nida, S. (2022). Hepato-Protective Effects of Delta-Tocotrienol and Alpha-Tocopherol in Patients with Non-Alcoholic Fatty Liver Disease: Regulation of Circulating MicroRNA Expression. International Journal of Molecular Sciences, 24(1), 79. https://doi.org/10.3390/ijms24010079
Pervez, M. A., Khan, D. A., Mirza, S. A., Slehria, A. U. R., Nisar, U., & Aamir, M. (2022). Comparison of delta-tocotrienol and alpha-tocopherol effects on hepatic steatosis and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: A randomized double-blind active-controlled trial. Complementary Therapies in Medicine, 70, 102866. https://doi.org/10.1016/j.ctim.2022.102866
Pervez, M. A., Khan, D. A., Slehria, A. U. R., & Ijaz, A. (2020). Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial. Complementary Therapies in Medicine, 52, 102494. https://doi.org/10.1016/j.ctim.2020.102494
Phang, S. C. W., Ahmad, B., Abdul Kadir, K., & M Palanisamy, U. D. (2023). Effects of Tocotrienol-Rich Fraction Supplementation in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Advances in Nutrition, 14(5), 1159–1169. https://doi.org/10.1016/j.advnut.2023.06.006
Sarakhan, L., Savytskyi, I., Znamerovskyi, S., & Pandey, S. (2025). The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus against the background of obesity and determination of the efficacy of complex pathogenetic correction. Journal of Education, Health and Sport, 85, 72606. https://doi.org/10.12775/JEHS.2025.85.72606
Sen, C. K., Khanna, S., & Roy, S. (2006). Tocotrienols: Vitamin E beyond tocopherols. Life Sciences, 78(18), 2088–2098. https://doi.org/10.1016/j.lfs.2005.12.001
Sharif, R., Wai, M. K., Choon, O. T., Abdul Hafid, S. R., & Lee, T. Y. (2025a). Tocotrienol-Enriched Beverage Enhances Psychological Well-Being, Antioxidant Defense, and Genomic Stability in Older Adults: A Randomized Controlled Trial. Nutrients, 17(13), 2179. https://doi.org/10.3390/nu17132179
Slivka, A., Rink, C., Paoletto, D., & Sen, C. K. (2020). Platelet function in stroke/transient ischemic attack patients treated with tocotrienol. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 34(9), 11838–11843. https://doi.org/10.1096/fj.201902216RR
Sudoł, M., Dąbek, K., Ochwat, M., Piekarska, M., Skowronek, A., Kajtel, A., Mierzwa, G., & Sudoł, Z. (2024). Are GLP-1 Analogues a New Solution for the Treatment of NAFLD? Quality in Sport, 35, 56304–56304. https://doi.org/10.12775/QS.2024.35.56304
Suleman, F., Khan, D. A., Pervez, M. A., & Aamir, M. (2022). Effects of delta-tocotrienol supplementation on glycaemic control in individuals with prediabetes—A randomized controlled study. Journal of the Pakistan Medical Association, 72(01), 4–7. https://doi.org/10.47391/JPMA.966
Traber, M. G. (2007). Vitamin E regulatory mechanisms. Annual Review of Nutrition, 27, 347–362. https://doi.org/10.1146/annurev.nutr.27.061406.093819
Vafa, M., Haghighat, N., Moslehi, N., Eghtesadi, S., & Heydari, I. (2015). Effect of Tocotrienols enriched canola oil on glycemic control and oxidative status in patients with type 2 diabetes mellitus: A randomized double-blind placebo-controlled clinical trial. Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences, 20(6), 540–547. https://doi.org/10.4103/1735-1995.165945
Xiong, Z., Liu, L., Jian, Z., Ma, Y., Li, H., Jin, X., Liao, B., & Wang, K. (2023). Vitamin E and Multiple Health Outcomes: An Umbrella Review of Meta-Analyses. Nutrients, 15(15), 3301. https://doi.org/10.3390/nu15153301
Yoshida, Y., Niki, E., & Noguchi, N. (2003). Comparative study on the action of tocopherols and tocotrienols as antioxidant: Chemical and physical effects. Chemistry and Physics of Lipids, 123(1), 63–75. https://doi.org/10.1016/S0009-3084(02)00164-0
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Kinga Szymańska-Zdyb, Agata Trześniowska, Mateusz Gąbka, Dawid Suwała, Natalia Pokrywka, Olga Komar, Marek Kochański, Iga Barczak, Andrzej Guz, Wiktoria Karolina Nowak
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 167
Number of citations: 0
